Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Rating)’s share price traded down 1.9% during trading on Tuesday . The stock traded as low as GBX 26 ($0.32) and last traded at GBX 26.50 ($0.33). 49,264 shares were traded during mid-day trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.33).
Mereo BioPharma Group plc (MPH.L) Price Performance
The company has a 50-day moving average of GBX 26.50 and a two-hundred day moving average of GBX 26.50. The company has a debt-to-equity ratio of 164.26, a current ratio of 2.98 and a quick ratio of 2.92. The stock has a market capitalization of £89.76 million and a PE ratio of -0.21.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Stories
- Insiders Buy Archer Aviation, Is This Stock About To Take Off?
- Intuit Is About To Make a Move, But Which Way?
- 3 Late January Earnings Plays With Pop Potential
- Low-Priced Stocks Still Paying Dividends
- Why is the Chipotle Stock Price Surging This Week?
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
